|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US6103260A
(en)
|
1997-07-17 |
2000-08-15 |
Mcneil-Ppc, Inc. |
Simethicone/anhydrous calcium phosphate compositions
|
|
US20040076668A1
(en)
|
2002-07-03 |
2004-04-22 |
Pfizer Inc. |
Controlled-release pharmaceutical formulations
|
|
CA2518830A1
(en)
|
2003-03-14 |
2004-09-30 |
Merck & Co., Inc. |
Carboxamide spirohydantoin cgrp receptor antagonists
|
|
US7205293B2
(en)
|
2003-03-14 |
2007-04-17 |
Merck & Co., Inc. |
Benodiazepine spirohydantoin CGRP receptor antagonists
|
|
JO2355B1
(en)
|
2003-04-15 |
2006-12-12 |
ميرك شارب اند دوم كوربوريشن |
Hereditary calcitonin polypeptide receptor antagonists
|
|
WO2005041869A2
(en)
|
2003-10-24 |
2005-05-12 |
Josef Rettenmaier & Soehne Gmbh & Co., Kg |
Process for co-spray drying agents with dry silicified mcc
|
|
US7390798B2
(en)
|
2004-09-13 |
2008-06-24 |
Merck & Co., Inc. |
Carboxamide spirolactam CGRP receptor antagonists
|
|
CA2579847A1
(en)
|
2004-09-13 |
2006-03-23 |
Merck & Co., Inc. |
Bicyclic anilide spirolactam cgrp receptor antagonists
|
|
DE102004063755A1
(de)
|
2004-12-29 |
2006-07-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von CGRP-Antagonisten zur Behandlung und Vorbeugung von Hitzewallungen bei Patienten mit Prostatakrebs
|
|
CN101208303A
(zh)
|
2005-03-14 |
2008-06-25 |
默克公司 |
Cgrp受体拮抗剂
|
|
JP5773560B2
(ja)
|
2006-02-09 |
2015-09-02 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Ｃｅｔｐ阻害剤のポリマー製剤
|
|
CA2650932C
(en)
|
2006-05-09 |
2013-01-22 |
Merck & Co., Inc. |
Substituted spirocyclic cgrp receptor antagonists
|
|
JP5511657B2
(ja)
|
2007-06-05 |
2014-06-04 |
メルク・シャープ・アンド・ドーム・コーポレーション |
カルボキサミドヘテロ環式ｃｇｒｐ受容体アンタゴニスト
|
|
US8450327B2
(en)
|
2007-10-18 |
2013-05-28 |
Boehringer Ingelheim International Gmbh |
CGRP antagonists
|
|
JP2011504481A
(ja)
|
2007-11-22 |
2011-02-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
有機化合物
|
|
AU2009212514A1
(en)
|
2008-02-05 |
2009-08-13 |
Merck Sharp & Dohme Corp. |
Prodrugs of CGRP receptor antagonist
|
|
US8044043B2
(en)
|
2008-04-11 |
2011-10-25 |
Bristol-Myers Squibb Company |
CGRP receptor antagonists
|
|
US20150023888A1
(en)
|
2008-09-05 |
2015-01-22 |
Map Pharmaceuticals, Inc. |
Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine
|
|
EP3708163A1
(en)
|
2009-03-31 |
2020-09-16 |
Ligand Pharmaceuticals, Inc. |
Use of sparsentan for the treatment of chronic inflammatory diseases
|
|
US8765763B2
(en)
|
2009-06-05 |
2014-07-01 |
Boehringer Ingelheim International Gmbh |
Substituted piperazines as CGRP antagonists
|
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
|
JP2013542261A
(ja)
|
2010-11-12 |
2013-11-21 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ピペリジノンカルボキサミドインダンｃｇｒｐ受容体アンタゴニスト
|
|
TWI487706B
(zh)
|
2010-11-12 |
2015-06-11 |
Merck Sharp & Dohme |
六氫吡啶酮甲醯胺氮雜茚滿ｃｇｒｐ受體拮抗劑
|
|
EP2654423B1
(en)
|
2010-12-22 |
2016-12-07 |
Merck Sharp & Dohme Corp. |
Fused heterocyclic azaindane carboxamide cgrp receptor antagonists
|
|
EP2654421B1
(en)
|
2010-12-22 |
2016-10-19 |
Merck Sharp & Dohme Corp. |
Fused heterocyclic indane carboxamide as cgrp receptor antagonists
|
|
EP2654726A1
(en)
|
2011-03-08 |
2013-10-30 |
Zalicus Pharmaceuticals Ltd. |
Solid dispersion formulations and methods of use thereof
|
|
EP2685826B1
(en)
|
2011-03-18 |
2016-02-03 |
Merck Sharp & Dohme Corp. |
Piperidinone carboxamide spirohydantoin cgrp receptor antagonists
|
|
WO2013036861A1
(en)
|
2011-09-08 |
2013-03-14 |
Codexis, Inc |
Biocatalysts and methods for the synthesis of substituted lactams
|
|
US9487523B2
(en)
|
2012-03-14 |
2016-11-08 |
Merck Sharp & Dohme Corp. |
Process for making CGRP receptor antagonists
|
|
MX351657B
(es)
|
2012-03-14 |
2017-10-23 |
Merck Sharp & Dohme |
Sales de alcaloide de cinchona bis-cuaternarias como catalizadores de transferencia de fase asimétrica.
|
|
WO2013162769A1
(en)
|
2012-04-25 |
2013-10-31 |
Centric Research Institute |
Sensitization composition and method of use
|
|
US9174989B2
(en)
|
2012-05-09 |
2015-11-03 |
Merck Sharp & Dohme Corp. |
Process for making CGRP receptor antagonists
|
|
WO2013169567A1
(en)
|
2012-05-09 |
2013-11-14 |
Merck Sharp & Dohme Corp. |
Spirolactam cgrp receptor antagonists
|
|
EP2846798B1
(en)
|
2012-05-09 |
2018-04-04 |
Merck Sharp & Dohme Corp. |
Aliphatic spirolactam cgrp receptor antagonists
|
|
US9227973B2
(en)
|
2012-05-09 |
2016-01-05 |
Merck Sharp & Dohme Corp. |
Pyridine CGRP receptor antagonists
|
|
JP6310542B2
(ja)
|
2013-03-15 |
2018-04-11 |
トニックス ファーマシューティカルズ， インコーポレイテッド |
シクロベンザプリン塩酸塩およびアミトリプチリン塩酸塩の共融製剤
|
|
KR20210153745A
(ko)
|
2013-09-16 |
2021-12-17 |
머크 샤프 앤드 돔 코포레이션 |
Cgrp 수용체 길항제를 위한 제제
|
|
US20160346198A1
(en)
|
2014-02-05 |
2016-12-01 |
Merck Sharp & Dohme Corp. |
Novel disintegration systems for pharmaceutical dosage forms
|
|
JP6491669B2
(ja)
|
2014-02-05 |
2019-03-27 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Ｃｇｒｐ活性化合物の錠剤製剤
|
|
KR20170003527A
(ko)
|
2014-02-24 |
2017-01-09 |
유리젠 파마슈티컬스, 인코포레이티드 |
경구 투여용 펜토산 폴리설페이트 염의 조성물
|
|
KR102803917B1
(ko)
|
2014-08-22 |
2025-05-07 |
파르마＆ 슈바이츠 게엠베하 |
루카파립의 고 용량 강도 정제
|
|
CA2974578C
(en)
|
2015-01-23 |
2020-11-17 |
Grunenthal Gmbh |
Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function
|
|
EA201890578A1
(ru)
|
2015-09-24 |
2018-12-28 |
Тева Фармасьютикалз Интернэшнл Гмбх |
Предотвращение, лечение и снижение (персистирующей) посттравматической головной боли
|
|
US20180092899A1
(en)
|
2016-09-30 |
2018-04-05 |
Merck Sharp & Dohme Corp. |
Method of treating acute migraine with cgrp-active compound
|
|
RU2770066C2
(ru)
|
2017-03-02 |
2022-04-14 |
Бет Изрейэл Диконисс Медикал Сентер, Инк. |
Отбор пациентов с головной болью, восприимчивых к антителам, направленным против кальцитонин ген-родственного пептида
|
|
TWI754772B
(zh)
|
2017-09-06 |
2022-02-11 |
美商美國禮來大藥廠 |
用於治療偏頭痛之拉米迪坦(lasmiditan)與cgrp拮抗劑之組合療法
|
|
US20190135927A1
(en)
|
2017-09-29 |
2019-05-09 |
Bhl Patent Holdings, Llc |
Migraine, headache, chronic pain treatment, and prophylaxis options
|
|
WO2019087161A1
(en)
|
2017-11-06 |
2019-05-09 |
Auckland Uniservices Limited |
Peptide conjugate cgrp receptor antagonists and methods of preparation and uses thereof
|
|
US20190374518A1
(en)
|
2018-06-08 |
2019-12-12 |
Allergan Pharmaceuticals International Limited |
Treatment of migraine
|
|
US20190374520A1
(en)
*
|
2018-06-08 |
2019-12-12 |
Allergan Pharmaceuticals International Limited |
Treatment of migraine
|
|
TWI826514B
(zh)
|
2018-09-04 |
2023-12-21 |
美商美國禮來大藥廠 |
用於預防偏頭痛之拉米迪坦(lasmiditan)長期夜間投藥
|
|
JP2022517433A
(ja)
|
2019-01-20 |
2022-03-08 |
バイオヘイブン・ファーマシューティカル・ホールディング・カンパニー・リミテッド |
突出性の片頭痛を処置するためのｃｇｒｐアンタゴニスト
|
|
AU2020259461A1
(en)
|
2019-04-18 |
2021-11-11 |
Allergan Sales, Llc |
CGRP antagonists for the treatment of medication overuse headache, post-traumatic headache, post-concussion syndrome and vertigo
|
|
US20210121541A1
(en)
|
2019-07-05 |
2021-04-29 |
Allergan Pharmaceuticals International Limited |
CGRP Antagonists and Clostridial Derivatives for the Treatment of Neuropsychiatric and Neurological Disorders
|
|
CA3156009A1
(en)
|
2019-09-25 |
2021-04-01 |
Allergan Pharmaceuticals International Limited |
POLYTHERAPY WITH CGRP ANTAGONISTS
|
|
CN116390712A
(zh)
|
2020-07-29 |
2023-07-04 |
阿勒根制药国际有限公司 |
治疗偏头痛
|
|
CA3206184A1
(en)
|
2020-12-22 |
2022-06-30 |
Allergan Pharmaceuticals International Limited |
Treatment of migraine
|
|
WO2023049920A1
(en)
|
2021-09-27 |
2023-03-30 |
Allergan Pharmaceuticals International Limited |
Combination comprising atogepant for treating migraine
|
|
JP2025508004A
(ja)
|
2022-03-09 |
2025-03-21 |
アラガン ファーマスーティカルズ インターナショナル リミテッド |
片頭痛の予防的治療
|